Bank of Nova Scotia’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-44,152
| Closed | -$135K | – | 981 |
|
|
2024
Q1 | $135K | Hold |
44,152
| – | – | ﹤0.01% | 954 |
|
|
2023
Q4 | $142K | Hold |
44,152
| – | – | ﹤0.01% | 949 |
|
|
2023
Q3 | $170K | Buy |
44,152
+133
| +0.3% | +$511 | ﹤0.01% | 950 |
|
|
2023
Q2 | $144K | Buy |
44,019
+663
| +2% | +$2.18K | ﹤0.01% | 978 |
|
|
2023
Q1 | $112K | Sell |
43,356
-2,125
| -5% | -$5.48K | ﹤0.01% | 1094 |
|
|
2022
Q4 | $84.6K | Buy |
45,481
+159
| +0.4% | +$296 | ﹤0.01% | 1124 |
|
|
2022
Q3 | $83K | Buy |
45,322
+230
| +0.5% | +$421 | ﹤0.01% | 1110 |
|
|
2022
Q2 | $97K | Sell |
45,092
-2,258
| -5% | -$4.86K | ﹤0.01% | 1120 |
|
|
2022
Q1 | $149K | Buy |
47,350
+5,124
| +12% | +$16.1K | ﹤0.01% | 1146 |
|
|
2021
Q4 | $136K | Buy |
+42,226
| New | +$136K | ﹤0.01% | 1142 |
|